# REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults

> **NCT07155265** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Yancheng First People's Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Critical Illness; Mechanical Ventilation; Shock

## Interventions

- **DRUG:** Remimazolam Besylate
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT07155265
- **Lead sponsor:** Yancheng First People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155265, "REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07155265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*